Crossmark

Liraglutide exhibits anti-inflammatory activity through the activation of the PKA/CREB pathway

Published Online: 2019-10-11

Published Print: 2019-12

Authors

Wang, Li http://orcid.org/0000-0002-9798-5234
Feng, Linjie

Zhang, Jingyu
License Information

Text and Data Mining valid from 2019-10-11

Version of Record valid from 2019-10-11
More Information

Article History

Received: 11 July 2019

Accepted: 27 September 2019

First Online: 11 October 2019

Ethics approval and consent to participate

: Not applicable.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current